Medication info
Janugriptin 100 mg Tablets (Sitagliptin Hydrochloride Monohydrate)

Janugriptin 100 mg Tablets (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.37mg / 1 tablet
Manufacturer / importer
Shias Pharmaceutical Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202108143 · Approved 2021.12.29 · Insurance code 689001760

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer this medicine at a dose of 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dosage adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Shias Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is primarily used to help control blood sugar levels in patients with type 2 diabetes. It can be administered alone or in combination with dietary and exercise therapy, and for those starting diabetes medication, if it is difficult to control blood sugar levels with monotherapy, it can be used in combination with Metformin. Additionally, if sufficient blood sugar control has not been achieved with monotherapy using sulfonylureas, Metformin, thiazolidinediones, or insulin, this medication can be added for further treatment. It is effective in improving blood sugar control across various treatment stages with flexible utilization.

How to take

Adult dose

For monotherapy or combination therapy, administer this medicine at a dose of 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Because dosage adjustment according to renal function is required, assessment of renal function is recommended before treatment with this medicine and periodically thereafter. No dosage adjustment is required in patients with mild renal impairment (eGFR ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). No dosage adjustment is required in patients with moderate renal impairment (eGFR ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). In patients with moderate renal impairment (eGFR ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. In patients with severe renal impairment (eGFR ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (eGFR < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication can cause severe allergic reactions in some patients. These reactions may occur within the first 3 months of taking the medication, and if symptoms such as hives, skin rash, or difficulty breathing occur, use should be stopped immediately and consultation with healthcare professionals is advised. Additionally, this medication may cause inflammation of the pancreas, so if symptoms like abdominal pain, vomiting, or loss of appetite appear during use, immediate medical attention is required. This medication should not be taken by patients with type 1 diabetes or those with certain allergies. Patients with decreased kidney function may require dosage adjustments, so regular kidney function testing should be performed during use. Cold-like symptoms, headache, diarrhea, and nausea may occur while taking this medication, and if symptoms are severe, consulting a physician is advised. When taken with insulin or other hypoglycemic agents, the risk of hypoglycemia may increase, so blood sugar levels should be monitored frequently, and immediate action is required if symptoms of hypoglycemia occur. If joint pain or blistering occurs, use of this medication should be stopped immediately and medical advice should be sought. Pregnant or breastfeeding women should avoid taking this medication, and safety in children under 18 years has not been adequately validated. In the case of overdose, immediate treatment is required, and some of it can be removed by hemodialysis, so medical guidance should be followed. This medication does not have significant interactions with many other drugs, but caution is necessary when used in combination with specific medications; therefore, all medications being taken must be reported to healthcare providers.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory tract infection
  • headache
Show 30 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe joint pain with disability
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetes complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air and moisture ingress, and it is safe to store at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication and prevents deterioration.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.